THE SMART TRICK OF PROTEINASE K INACTIVATION THAT NO ONE IS DISCUSSING

The dearth of ER, HER2, and PR expression in triple negative breast tumors offers an important obstacle in building focused therapies (Katz and Alsharedi 2017). To address this, a number of reports have appeared into unique procedures that could be qualified in TNBC without having a wider systemic impact (Katz and Alsharedi 2017). Gene expression a